Skip to main content
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1961 Feb;16(1):82–89. doi: 10.1111/j.1476-5381.1961.tb00300.x

The actions of amylobarbitone sodium, butobarbitone and quinalbarbitone sodium upon insomnia and nocturnal restlessness compared in psychiatric patients

J M Hinton
PMCID: PMC1482001  PMID: 13714480

Abstract

Amylobarbitone sodium, butobarbitone, quinalbarbitone sodium, and a placebo were compared in a controlled, double-blind trial in psychiatric patients with insomnia. An apparatus recording movement in bed is described, with sleep assessments by night nurses and patients. All three barbiturates significantly reduced movement and gave significantly longer, less broken and sounder sleep, without increased incidence of “hang-over.” There was no follow-on effect from night to night. With effective doses there was no significant difference between these barbiturates in onset and duration of hypnotic action, although usually accepted as either short or intermediate acting.

Full text

PDF
82

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BRODIE B. B., BURNS J. J., MARK L. C., LIEF P. A., BERNSTEIN E., PAPPER E. M. The fate of pentobarbital in man and dog and a method for its estimation in biological material. J Pharmacol Exp Ther. 1953 Sep;109(1):26–34. [PubMed] [Google Scholar]
  2. COX G. H., MARLEY E. The estimation of motility during rest or sleep. J Neurol Neurosurg Psychiatry. 1959 Feb;22(1):57–60. doi: 10.1136/jnnp.22.1.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. GOODNOW R. E., BEECHER H. K., BRAZIER M. A. B., MOSTELLER K., TAGIURI R. Physiological performance following a hypnotic dose of a barbiturate. J Pharmacol Exp Ther. 1951 May;102(1):55–61. [PubMed] [Google Scholar]
  4. HINTON J. M., MARLEY E. The effects of meprobamate and pentobarbitone sodium on sleep and motility during sleep: a controlled trial with psychiatric patients. J Neurol Neurosurg Psychiatry. 1959 May;22(2):137–140. doi: 10.1136/jnnp.22.2.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. LASAGNA L. A study of hypnotic drugs in patients with chronic diseases; comparative efficacy of placebo; methyprylon (noludar) meprobmate (miltown, equanil) pentobarbial; phenobarbital; secobarbital. J Chronic Dis. 1956 Feb;3(2):122–133. doi: 10.1016/0021-9681(56)90108-4. [DOI] [PubMed] [Google Scholar]
  6. STEWART J. S. Clinical trial of methyprylone, a piperidine hypnotic. Br Med J. 1956 Dec 22;2(5007):1465–1467. doi: 10.1136/bmj.2.5007.1465. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES